Dual targeting of RANKL and PD-1 with a bispecific antibody improves anti-tumor immunity
- Type
- Retraction
- Notice date
- 2/23/2022 0:00
- Journal
- Clinical & Translational Immunology
- Publisher
- Wiley
- Notice DOI
- 10.1002/cti2.1378
- Original paper DOI
- 10.1002/cti2.1081
Reasons
- Falsification/Fabrication of Image
- Investigation by Company/Institution
- Misconduct - Official Investigation(s) and/or Finding(s)
- Misconduct by Author
- Unreliable Results and/or Conclusions